REGULATORY

First Abortion Pill Candidate in Japan Up for Panel Review on Jan. 27

January 23, 2023

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

A key Japanese health ministry panel will be discussing whether to approve Linepharma’s combination pack of mifepristone and misoprostol tablets at its meeting on January 27. A successful approval will make the medicines the first abortion pills to be marketed…

To read the full story

MHLW Panel to Discuss Semaglutide for Obesity, Precedex, Entyvio SC on Jan. 27
January 17, 2023
Linepharma Submits NDA for Abortion Pills in Japan
December 23, 2021

REGULATORY

Govt Eyes Honebuto Revisions on Biosimilars, MFN Policy
July 7, 2026
LDP Launches Alzheimer’s League, Experts Call for Earlier Intervention
July 7, 2026
LDP, Ishin Near Deal on Chuikyo Reform to Bolster Drug Discovery
July 7, 2026
Japan, US Launch Talks on Pharma GMP MRA to Ease Inspection Burden
July 3, 2026
MHLW Gives Kissei until July 21 to Report on Tavneos
July 3, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Romiplate to See Steepest Cut in April Market Expansion Re-Pricing

Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…

COMMENTARY

DORA Use Could Expand as Japan Opens Door to “Sleep Disorders” Specialty

By Shinya Sato

Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…

COLUMN

The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard

By Philip Carrigan

Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…